Aprogen Healthcare & Games Inc
Aprogen Healthcare & Games Inc. engages in the development of medicines using biomedical technology. The company operates through Game Business, Rental Profit, and Pharmaceutical divisions. It offers specialty drugs, such as antibiotics, circulatory system, digestive system, anti-inflammatory, and analgesic drugs. The company also offers wireless remote lighting monitoring and control system for … Read more
Aprogen Healthcare & Games Inc (109960) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.002x
Based on the latest financial reports, Aprogen Healthcare & Games Inc (109960) has a cash flow conversion efficiency ratio of 0.002x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩699.57 Million) by net assets (₩309.52 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Aprogen Healthcare & Games Inc - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how Aprogen Healthcare & Games Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Aprogen Healthcare & Games Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Aprogen Healthcare & Games Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
EZZ Life Science Holdings Ltd
AU:EZZ
|
-0.198x |
|
Refinaria de Petróleos de Manguinhos S.A
SA:RPMG3
|
-0.004x |
|
Chemlite Innovation Berhad
KLSE:0348
|
N/A |
|
Cavitation Techs Inc
OTCQB:CVAT
|
1.159x |
|
NAXS Nordic Access Buyout Fund AB
ST:NAXS
|
-0.003x |
|
Sundaram Brake Linings Limited
NSE:SUNDRMBRAK
|
0.250x |
|
Bank Cimb Niaga Tbk
JK:BNGA
|
-0.027x |
|
Jaypee Infratech Limited
NSE:JPINFRATEC
|
0.003x |
Annual Cash Flow Conversion Efficiency for Aprogen Healthcare & Games Inc (2013–2024)
The table below shows the annual cash flow conversion efficiency of Aprogen Healthcare & Games Inc from 2013 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩301.81 Billion | ₩4.71 Billion | 0.016x | +169.57% |
| 2023-12-31 | ₩287.26 Billion | ₩1.66 Billion | 0.006x | -93.34% |
| 2022-12-31 | ₩198.89 Billion | ₩17.28 Billion | 0.087x | +245.56% |
| 2021-12-31 | ₩222.62 Billion | ₩-13.29 Billion | -0.060x | -508.77% |
| 2020-12-31 | ₩231.83 Billion | ₩3.39 Billion | 0.015x | +211.79% |
| 2019-12-31 | ₩210.50 Billion | ₩986.07 Million | 0.005x | -76.65% |
| 2018-12-31 | ₩217.46 Billion | ₩4.36 Billion | 0.020x | +213.50% |
| 2017-12-31 | ₩114.81 Billion | ₩734.70 Million | 0.006x | +100.57% |
| 2016-12-31 | ₩8.64 Billion | ₩-9.71 Billion | -1.124x | -759.29% |
| 2015-12-31 | ₩15.08 Billion | ₩-1.97 Billion | -0.131x | -147.38% |
| 2013-12-31 | ₩4.40 Billion | ₩1.22 Billion | 0.276x | -- |